Macrolides, tetracyclines, lincosamides and oxazolidinones
Ribosomal targets, spectrum, resistance and the mechanism-based adverse effects and interactions of macrolides, tetracyclines, clindamycin and linezolid, including QT prolongation, CYP3A4 inhibition, toxin suppression and serotonin toxicity.
Tier 2Medical sciences concept
Written with AI assistance and fact-checked against the sources below. For exam study, not clinical decisions. How notes are made
At a glance
- All four classes bind the bacterial ribosome. Tetracyclines bind the 30S subunit; macrolides, lincosamides (clindamycin) and oxazolidinones (linezolid) bind the 50S subunit. Most are bacteriostatic.
- Human ribosomes are 80S, which gives selectivity. Mitochondrial ribosomes are bacterial in origin, which explains linezolid's marrow, nerve and lactate toxicity with long courses.
- The examinable adverse effects follow from mechanism: QT prolongation and CYP3A4 inhibition with macrolides, chelation and photosensitivity with tetracyclines, C. difficile with clindamycin, and serotonin toxicity with linezolid.
Loading the rest of the note…
Finished reading?
Sources
- Therapeutic Guidelines: AntibioticAU/NZTherapeutic Guidelines Limited
- Australian Medicines HandbookAU/NZAustralian Medicines Handbook Pty Ltd, 2026
- Goodman & Gilman's The Pharmacological Basis of Therapeutics (14th ed.)McGraw Hill (Brunton and Knollmann, 2023), 2023
- M100: Performance Standards for Antimicrobial Susceptibility Testing (35th ed.)Clinical and Laboratory Standards Institute, 2025
- Last updated
- 14 November 2026
What changed
- 14 November 2026 Turnstile bot check on sign-in and signed-out feedback